Sargent Investment Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $230K | Sell |
9,550
-427
| -4% | -$11.2K | 0.03% | 251 |
|
|
2026
Q1 | $280K | Sell |
9,977
-1,467
| -13% | -$39.1K | 0.04% | 212 |
|
|
2025
Q4 | $285K | Buy |
+11,444
| New | +$289K | 0.04% | 215 |
|
|
2025
Q3 | – | Sell |
-9,967
| Closed | -$239K | – | 200 |
|
|
2025
Q2 | $239K | Buy |
9,967
+1,620
| +19% | +$37.8K | 0.03% | 216 |
|
|
2025
Q1 | $212K | Buy |
8,347
+254
| +3% | +$6.65K | 0.03% | 214 |
|
|
2024
Q4 | $217K | Buy |
8,093
+536
| +7% | +$14.5K | 0.04% | 215 |
|
|
2024
Q3 | $219K | Sell |
7,557
-1,150
| -13% | -$33.5K | 0.04% | 197 |
|
|
2024
Q2 | $244K | Buy |
8,707
+250
| +3% | +$6.88K | 0.05% | 187 |
|
|
2024
Q1 | $235K | Sell |
8,457
-6,982
| -45% | -$194K | 0.05% | 178 |
|
|
2023
Q4 | $444K | Buy |
15,439
+10
| +0.1% | +$302 | 0.1% | 132 |
|
|
2023
Q3 | $512K | Buy |
15,429
+530
| +4% | +$18.7K | 0.12% | 114 |
|
|
2023
Q2 | $546K | Sell |
14,899
-919
| -6% | -$35.8K | 0.13% | 111 |
|
|
2023
Q1 | $654K | Buy |
15,818
+762
| +5% | +$32.9K | 0.17% | 100 |
|
|
2022
Q4 | $771K | Buy |
15,056
+600
| +4% | +$28.8K | 0.24% | 87 |
|
|
2022
Q3 | $623K | Hold |
14,456
| – | – | 0.19% | 93 |
|
|
2022
Q2 | $758K | Sell |
14,456
-115
| -0.8% | -$5.86K | 0.23% | 80 |
|
|
2022
Q1 | $754K | Sell |
14,571
-46
| -0.3% | -$2.39K | 0.19% | 94 |
|
|
2021
Q4 | $863K | Buy |
14,617
+386
| +3% | +$19.1K | 0.2% | 85 |
|
|
2021
Q3 | $612K | Sell |
14,231
-1,000
| -7% | -$44.3K | 0.15% | 104 |
|
|
2021
Q2 | $596K | Sell |
15,231
-165
| -1% | -$6.42K | 0.14% | 109 |
|
|
2021
Q1 | $558K | Buy |
15,396
+827
| +6% | +$29.4K | 0.15% | 108 |
|
|
2020
Q4 | $536K | Buy |
14,569
+603
| +4% | +$22.1K | 0.17% | 97 |
|
|
2020
Q3 | $486K | Buy |
13,966
+685
| +5% | +$24K | 0.18% | 99 |
|
|
2020
Q2 | $425K | Hold |
13,281
| – | – | 0.16% | 103 |
|
|
2020
Q1 | $411K | Sell |
13,281
-321
| -2% | -$10.9K | 0.19% | 92 |
|
|
2019
Q4 | $506K | Sell |
13,602
-843
| -6% | -$30K | 0.19% | 98 |
|
|
2019
Q3 | $492K | Buy |
14,445
+1,379
| +11% | +$50.1K | 0.22% | 93 |
|
|
2019
Q2 | $537K | Buy |
13,066
+2,108
| +19% | +$83.7K | 0.25% | 84 |
|
|
2019
Q1 | $442K | Buy |
+10,958
| New | +$439K | 0.21% | 85 |
|
Other funds holding PFE
Sargent Investment Group's PFE Position: Q2 2026 in Review
Sargent Investment Group reduced its Pfizer (PFE) stake by 4.3% in Q2 2026, selling an estimated $11.2K and leaving 9,550 shares worth $230K. The position accounts for 0.03% of the portfolio, ranked #251.
Sargent Investment Group first reported a position in PFE in Q1 2019 and has held it in 29 quarters since. The position peaked at $863K in Q4 2021. 2,835 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Sargent Investment Group held 9,550 shares of Pfizer worth $230K as of Q2 2026.
- Sargent Investment Group sold 427 Pfizer shares in Q2 2026, an estimated $11.2K.
- Pfizer made up 0.03% of Sargent Investment Group's portfolio in Q2 2026, its #251 holding.
- Sargent Investment Group first reported a position in Pfizer in Q1 2019 and has held it in 29 quarters since.
- Sargent Investment Group's Pfizer position peaked at $863K in Q4 2021.
- 2,835 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Sargent Investment Group's 13F filing for Q2 2026, filed 11 Aug 2026.